Director, Nonclinical Due Diligence & External Innovation

ppThe Director Non-Clinical Due Diligence External Evaluations providesscientific leadership for nonclinical due diligencesupporting CSL’s in-licensing, acquisitions, and strategic collaborations. The role ensuresintegrated, objective, and decision-relevant evaluationsof nonclinical pharmacology, PK/QSP, and toxicology data to identify development risks, data gaps, and mitigation strategies and to inform portfolio decisions. /p pThe incumbent will further act as nonclinical representative for selected Research programs and support oversight of nonclinical strategies and programs across all Therapeutic Areas. /p pThe role reports to the Executive Director, Head of Nonclinical Development. /p h3Responsibilities and accountabilities /h3 ul lipLeadsoperational executionof nonclinical due diligence for assigned opportunities. /p /li lipActs ashands‑on scientific integrator, translating expert input into clear risk narratives. /p /li lipTrusted subject‑matter lead for nonclinical DD on individual deals. /p /li lipLead end-to-end nonclinical due diligence for individual assets or transactions, from request through final governance readout. /p /li lipIntegrate input from Toxicology, PK/QSP, Nonclinical Pharmacology, and external experts intoasingle, coherent scientific assessment. /p /li lipIdentifyFIH‑enabling gaps, translational risks, and regulatory limitations, with clear mitigation proposals. /p /li lipPrepare high‑quality DD reports, executive summaries, and risk tables for governance review. /p /li lipAct as NCD scientific interface to Business Development and Therapeutic Area teams at the project level. /p /li lipContribute to maintenance and continuous improvement of nonclinical DD frameworks and templates. /p /li lipMentor junior contributors and matrix team members as appropriate. /p /li lipEscalates complex or high‑impact issues to Head of NCD /p /li lipChair of "NCD Review Committee" /p /li /ul h3Qualifications: /h3 h3Education: /h3 ul lipAdvanced degree (Ph.D., D.V.M., or equivalent) in toxicology, pharmacology, or a related field /p /li lipToxicology training, board certification preferred /p /li /ul h3Experience : /h3 ul lipExperience in nonclinical development (10+ years) with proven experience in due diligence or external innovation, ideally across various geographies. /p /li lipStrong understanding of FIH‑enabling nonclinical requirements, particularly for biologics and complex modalities. /p /li lipAbility to communicate complex scientific risk clearly to non‑expert stakeholders. /p /li lipExperience across multiple therapeutic areas and modalities is highly desirable. /p /li /ul h3Competencies: /h3 ul lipProven ability to work effectively both independently or in a team setting, and to meet set goals by managing own timelines. /p /li lipExperience in working in cross-functional, multicultural and international teams. /p /li lipExcellent communication and analytical skills. /p /li lipExperience in analyzing and presenting research results to scientific and professional audiences. /p /li lipStrong planning and organizational skills. /p /li lipAbility to work successfully in a matrix organizational structure. /p /li lipStrong negotiation skills and ability to identify and engage internal and external expertise as needed. /p /li lipGood understanding of drug development process, strong knowledge of ICH/GLP /p /li lipFluent in English, oral and written; /p /li /ul pThe role requires onsite presence 3 days per week. /p pThe role can be based in Zurich, Switzerland or Waltham, USA. /p /p #J-18808-Ljbffr